Wenjun Zhan

No ORCID on file · 1 paper in corpus · active 2026

Study types

  • other 1

Condition tags

  • endometriosis 1
other 2026
Journal of controlled release : official journal of the Controlled Release Society ·doi:10.1016/j.jconrel.2026.115007

Fibroblast growth factor receptor 2 (FGFR2) has emerged as a highly promising therapeutic target due to its critical role in the pathogenesis and progression of endometriosis. To date, a variety of FGFR2 inhibitors have exhibited remarkable…